王 錦莉

Medicine & Life Sciences

1. Taiwan 100%
2. Precursor Cell Lymphoblastic Leukemia-Lymphoma 92%
3. Pediatrics 86%
4. ErbB Receptors 69%
5. Adenocarcinoma of Lung 56%
6. Survival 45%
7. Lung Neoplasms 42%
8. cold agglutinins 33%
9. Mycoplasma Pneumonia 29%
10. DiGeorge Syndrome 29%
11. Thrombocytosis 27%
12. Mucocutaneous Lymph Node Syndrome 27%
13. Papillomavirus Infections 26%
14. Thymic aplasia 26%
15. Circulating Neoplastic Cells 26%
16. Hyperbilirubinemia 25%
17. Preclinical Drug Evaluations 25%
18. Residual Neoplasm 24%
19. Haemolytic Anaemia 24%
20. Neoplasms 24%
21. Second Primary Neoplasms 24%
22. Oncogene Proteins 23%
23. Smoking 23%
24. Sarcoma 23%
25. Precision Medicine 22%
26. Acute Myeloid Leukemia 22%
27. Drug Therapy 21%
28. Mycoplasma pneumoniae 20%
29. Progression-Free Survival 20%
30. Glioma 19%
31. Aspirin 19%
32. Therapeutics 19%
33. Cytogenetic Analysis 19%
34. Child 19%
35. Cisplatin 19%
36. Mutation 19%
37. Non-Small Cell Lung Carcinoma 19%
38. Central Nervous System 17%
39. Radiation 17%
40. Young Adult 17%
41. Sepsis 17%
42. Genotype 16%
43. Chromosomes 16%
44. Survival Rate 16%
45. Steroids 15%
46. Meta-Analysis 15%
47. Systematic Reviews 15%
48. Polyploidy 15%
49. Confidence Intervals 14%
50. Bilirubin 13%